Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...

The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable ...

Control-IQ+ automated insulin delivery technology from Tandem Diabetes Care cleared by FDA for people with type 2 diabetes.

Transplanting insulin-producing cells along with engineered blood-vessel-forming cells has successfully reversed type 1 ...

Childhood cancer treatments, specifically total body irradiation, were associated with increased risk of developing diabetes among cancer survivors.

Incident type 2 diabetes risk was associated with metabolic syndrome and dyslipidemia especially among patients younger than 55 years of age.

Tandem Diabetes Care announced that the FDA cleared its Control-IQ+ automated insulin delivery algorithm for people with type ...

A new drug trial is using a vaccine that has been around for more than 100 years, to help people living with type one diabetes. Doctor Denise Faustman, a researcher at Mass General Hospital and ...

Researchers at The University of Colorado Anschutz Medical Campus and colleagues at Massachusetts General Hospital, have ...

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings tomorrow after the bell. Here’s ...

Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...